ADAM12 is a potential therapeutic target regulated by hypomethylation in triple-negative breast cancer

  1. Mendaza, S.
  2. Ulazia-Garmendia, A.
  3. Monreal-Santesteban, I.
  4. Córdoba, A.
  5. de Azúa, Y.R.
  6. Aguiar, B.
  7. Beloqui, R.
  8. Armendáriz, P.
  9. Arriola, M.
  10. Martín-Sánchez, E.
  11. Guerrero-Setas, D.
Aldizkaria:
International Journal of Molecular Sciences

ISSN: 1422-0067,  1661-6596

Argitalpen urtea: 2020

Alea: 21

Zenbakia: 3

Mota: Artikulua

DOI: 10.3390/IJMS21030903 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus